Skip to main content
OpenTrials

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies
Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

NCT00015652

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +17 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Univ. of Iowa Healthcare, Div. of Infectious Diseases Iowa City, Iowa, United States
View Trial Details
Completed

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

NCT00008463

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +23 more
Locations
  • Ucsd, Avrc Crs San Diego, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
View all 24 locations
View Trial Details
Completed

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

NCT00393276

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +17 more
Locations
  • UCSD Antiviral Research Center CRS San Diego, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • IHV Baltimore Treatment CRS Baltimore, Maryland, United States
View Trial Details
Completed

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

NCT04211909

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-D, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Dong-A University Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
View all 22 locations
View Trial Details
Completed

Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection

NCT01587586

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Changhua Christian Hospital Changhua, Taiwan
  • National Taiwan University Hospital - Yunlin Douliu, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Chang Gung Medical Foundation - Kaohsiung Kaohsiung City, Taiwan
View all 13 locations
View Trial Details
Completed

A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects

NCT02486406

Conditions
Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +9 more
Locations
  • UCSF Benioff Childrens Hosp /ID# 136774 San Francisco, California, United States
  • Children's Hospital Colorado /ID# 137017 Aurora, Colorado, United States
  • University of Florida - Archer /ID# 136830 Gainesville, Florida, United States
  • Advent Health /ID# 167663 Orlando, Florida, United States
View all 21 locations
View Trial Details
Completed

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

NCT01185028

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +19 more
Locations
  • Family Medical and Counseling Services, SE Washington D.C., District of Columbia, United States
  • Unity Health Care/Walker Jones, NE Washington D.C., District of Columbia, United States
  • Whitman Walker Clinic, NW Washington D.C., District of Columbia, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details

Related conditions